| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850749 | American Journal of Kidney Diseases | 2008 | 11 Pages |
Abstract
Pentoxifylline added to losartan therapy for 1 year decreased proteinuria in patients with CKD stages 3 to 5. A large-scale clinical trial is necessary to confirm this result.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Shuei-Liong MD, PhD, Yung-Ming MD, Wen-Chih MD, PhD, Kwan-Dun MD, PhD, Tun-Jun MD, PhD,